EQUILLIUM, INC. (EQ) Debt Components
- 2023-03-31: Notes Payable, CurrentUSD $5.71M; Long-term Debt, Current MaturitiesUSD $5.71M; Long-term Debt, Excluding Current MaturitiesUSD $1.84M; Notes PayableUSD $7.60M.
- 2022-12-31: Notes Payable, CurrentUSD $5.71M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Notes PayableUSD $9.00M.
- 2022-12-31: Notes Payable, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD $5.71M; Long-term Debt, Excluding Current MaturitiesUSD $3.24M; Notes PayableUSD (m).
- 2022-09-30: Notes Payable, CurrentUSD $5.71M; Long-term Debt, Current MaturitiesUSD $5.71M; Long-term Debt, Excluding Current MaturitiesUSD $4.62M; Notes PayableUSD $10.30M.
EQUILLIUM, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Notes Payable USD | Long-term Debt USD | Debt Instrument, Unamortized Discount USD | Notes Payable, Related Parties, Noncurrent USD |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | $5.71M | $5.71M | $1.84M | $7.60M | $7.64M | $36.00K | (m) |
| 2022-12-31 | $5.71M | (m) | (m) | $9.00M | (m) | (m) | (m) |
| 2022-12-31 | (m) | $5.71M | $3.24M | (m) | $9.07M | $48.00K | (m) |
| 2022-09-30 | $5.71M | $5.71M | $4.62M | $10.30M | $10.33M | $70.00K | (m) |
| 2022-06-30 | $4.29M | $4.29M | $5.99M | $10.30M | $10.28M | $91.00K | (m) |
| 2022-03-31 | $2.86M | $2.86M | $7.37M | $10.20M | $10.23M | $112.00K | (m) |
| 2021-12-31 | $1.43M | (m) | (m) | $10.20M | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.43M | $8.75M | (m) | $10.18M | $132.00K | (m) |
| 2021-09-30 | $1.25M | $1.25M | $8.87M | $10.10M | $10.12M | $154.00K | (m) |
| 2021-06-30 | (m) | $0.00 | $10.07M | $10.10M | $10.07M | $177.00K | (m) |
| 2021-03-31 | $2.50M | $2.50M | $7.51M | $10.00M | $10.01M | $205.00K | (m) |
| 2020-12-31 | $1.67M | (m) | (m) | $9.90M | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.67M | $8.28M | (m) | $9.94M | $235.00K | (m) |
| 2020-09-30 | $833.00K | $833.00K | $9.04M | $9.90M | $9.88M | $265.00K | (m) |
| 2020-06-30 | (m) | (m) | $9.81M | (m) | $9.81M | $295.00K | (m) |
| 2020-03-31 | (m) | (m) | $9.75M | (m) | $9.75M | $325.00K | (m) |
| 2019-12-31 | (m) | (m) | (m) | $9.70M | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $9.68M | (m) | $9.68M | $354.00K | (m) |
| 2019-09-30 | (m) | (m) | $9.62M | (m) | $9.62M | $384.00K | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $1.27M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $1.06M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |